baber/WOPTO huggingface dataset:
Patent NZ-508684-A (NZ)
Title: High pressure particulates trap at wellhead
Inventor: VAUSE PETER ALAN
IPC: E21B43/34
Filed: 2000-12-07
Abstract: A trap for particulates in a fluid flow line between a wellhead and a choke having a casing defining a chamber and having an inlet to the chamber which is connected to the wellhead and an outlet from the chamber which is connected to the choke. A filter at the outlet retains particulates entrained in the fluid flowing through in the chamber, which may be opened to allow accumulated particulates to be cleared from the chamber. The inlet and outlet boss, which are attached to the inlet/outlet end respectively are screw-threaded to the casing, and are connected or connectable to a inlet/outlet flange which is attached to an inlet/outlet pipe. The outlet flange provides access means when not attached to the boss. The filter element is screw-threaded to the outlet flange so that removal of the outlet flange from the casing also removes the filter element from the casing to allow its replacement. Supporting means to support the weight of the outlet flange and the attached filter element when separated from the boss is provided by a gantry rail attached to the casing so that a distal end thereof extends above and beyond the outlet end of the casing, and a traveller on the rail which is connected to the outlet flange. The filter element comprises a perforated tube attached at one end to the outlet flange and closed at its distal end and covered between its ends with a tubular screen. The casing, bosses, flanges and any bolts used are made of high tensile steel with no welded joints in the trap. Installation of a second trap whereby one trap may be operational while the other is closed of to allow it to be emptied may be in parallel between the wellhead and the choke with each trap connected to a different choke. The trap has means of indicating differential pressure between the inlet and outlet end of the chamber. The fluid at the wellhead is at high pressure is induced to flow in the flow line by the choke being opened to some extent. The pressure at the wellhead is such as to enable fluid to flow through the partially opened choke at supersonic speeds and the choke is operated so that the fluid flows from the wellhead from the choke at subsonic speeds.
Patent NZ-509912-A (NZ)
Title: Wood reinforcing material having a carbon fibre reinforced thermosetting resin sheet covered by a porous phenol resin impregnated sheet
Inventor: IDE ISAMU
IPC: B32B5/28
Filed: 1999-08-05
Abstract: A phenol resin-impregnated sheet 1 formed by impregnating a porous resin sheet with a phenol resin having a degree of cure of 70% or more and 95% or less is disposed and laminated on the surface of a carbon fiber-reinforced thermosetting resin sheet 2.  When the thickness of the phenol resin impregnated sheet 1 is 0.01 mm or more and 1.0 mm or less, a wood reinforcing material with no unevenness and no curling and water proofness and strength can be obtained. The wood reinforcing material is integrated and cured on the surface of the wood material by way of the phenol resin-impregnated sheet 1 to reinforce wood material (single board or bonded board) to form a reinforced wood material. The wood reinforcing material is able to adhere with the wood material and in the handlability, results in no environmental contamination which would cause wastes such as release paper and has sufficient reinforcing effect to the wood material.
Patent NZ-513505-A (NZ)
Title: Phosphate and thiosulphate based fertilisers
Inventor: WILLIAMS RICHARD HENRY
IPC: C05G3/60
Filed: 2000-02-07
Abstract: A liquid fertiliser comprising a mixture of a phosphonate together with a thiosulphate such as ammonium or potassium thiosulphate optionally with a salicylic acid, salt or derivative such as or salicylamide.  The fertiliser can be used as a foliar spray, soil drench or irrigation component to stimulate plant growth or control parasitic fungi.
Patent NZ-516466-A (NZ)
Title: Sustained release compositions, process for producing the same and use thereof
Inventor: IGARI YASUTAKA
IPC: A61P15/00
Filed: 2000-07-13
Abstract: A sustained release composition comprising an active substance, a hydroxynaphthoic acid, a lactic acid-glycolic acid polymer; wherein the weight average molecular weight of said lactic acid-glycolic acid polymer based on the amount (micromoles) of the terminal carboxyl group per unit mass (grams) of said lactic acid-glycolic acid polymer is 1,200,000-3,000,000.  Said composition provides for a composition having the active substance at a high concentration while suppressing excessive initial release, thus giving a stable releasing rate.
Patent NZ-517855-A (NZ)
Title: Indeno[1,2-b]indol-10(5H)-one compounds and pharmaceutical compositions containing them
Inventor: WIERZBICKI MICHEL
IPC: C07D209/80
Filed: 2002-03-18
Abstract: A compound of formula (I), wherein: R is H or a linear or branched alkenyl or linear or branched alkyl group optionally substituted by a carboxy group or by a group of the formula -NRaRb. Each of R1-R8 independently represents H or a linear or branched alkyl group, a linear or branched alkenyl group, a hydroxy group, a linear or branched alkoxy group, a linear or branched alkenyloxy group, an arylalkyl group in which the alkyl moiety is linear or branched, an arylalkoxy group in which the alkoxy group is linear or branched, a carboxy group, a linear or branched acyloxy group, or an arylcarbonyloxy group.  Or one of the groups R1 to R8 forms with an adjacent one of the groups R1 to R8 a (C1-C2)alkylenedioxy group. With the proviso that: i) When R does not represent a H atom, then at least one of the groups R1 to R8 represents a hydroxy group or a linear or branched acyloxy group. ii) The compounds of formula (I) are other than [1,2-b]indol-10(5H)-one. Also described are pharmaceutical compositions comprising the compound of formula (I) in combination with one or more inert, non-toxic pharmaceutically acceptable carriers. The compounds of formula (I) are useful for treating disorders of the melatoninergic system.
Patent NZ-518865-A (NZ)
Title: Switchable permanent magnetic device
Inventor: UNDERWOOD PERRY JOHN
IPC: H01F7/04
Filed: 2000-12-06
Abstract: A switchable magnetic device includes a first magnet (10) and a second magnet (11), both of which are essentially cylindrical. Magnets (10, 11) are housed in a housing made from pole pieces (12,13). Pole pieces (12, 13) are ferromagnetic. Lower magnet (10) is fixedly mounted in the housing whilst upper magnet (11) can rotate within the housing. Upper magnet (11) is formed with notches or grooves (14, 15) along its vertical side walls. These notches or grooves (14, 15) receive downwardly depending arms (16, 17) of bar (18). Bar (18) is received inside a groove (19) formed on boss (20). Boss (20) is connected to a short bar (21) that, in turn, is fixedly connected to a handle or lever (22). By this means, rotation of handle or lever (22) causes rotation of second magnet (11). When the upper magnet (11) is positioned such that its north pole substantially overlies the south pole of lower magnet (10) and the south pole of upper magnet (11) substantially overlies the north pole of lower magnet (10), the first and second magnets act as an internal active magnetic shunt and as a result the external magnetic field strength from the device is quite low. Rotating the upper magnet (11) 180 DEG about its axis of rotation brings the magnets into alignment such that the respective north and south poles of the upper magnet (11) substantially overlie respective north and south poles of lower magnet (10). In this alignment, the external magnet field from the device is quite strong and the device can be affixed to surfaces or objects.
Patent NZ-520488-A (NZ)
Title: Kahalalide compounds
Inventor: ALBERICIO FERNANDO
IPC: C07K11/00
Filed: 2001-02-09
Abstract: A kahalalide F derivative which is not a mix of isomers known as kahalalide F, the derivative having a structure with a cyclic part and a side chain derived from formula (I), the derivative differing from formula (I) in one or more of the following respects: 1 or 2 amino acids which are not the same as an amino acid in the structure of formula (I); 1 to 10 additional methylene groups in the acyl group of the side chain of the structure of formula (I); 1 to 5 methylene groups omitted from the acyl group of the side chain of the structure of formula (I); 1 to 3 substituents added to the side chain acyl group of the structure of formula (I); omission of the 5-methyl substituent from the acyl group of the side chain; and omission of the acyl group of the side chain.
Patent NZ-523872-A (NZ)
Title: Pack for smoking articles
Inventor: LUTON COLIN DENNIS
IPC: B65D85/10
Filed: 2003-01-29
Abstract: A pack for elongate smoking articles comprising a lid hingedly connected to a body, both the lid and the body each having front, rear and a pair of side panels, the lid having a top panel remote from the body which has a base panel remote from the lid, said hinge connection being defined by a fold between the rear lid panel and the rear body panel and being substantially parallel to the top and bottom edges of the pack, the front of the pack having a portion that is cut away to reveal a backing member disposed within the pack and the hinge connection also being substantially parallel to an imaginary straight line extending between the lowermost points of the side edges of the front of the lid, wherein the lower edge of the front lid panel forms the upper extremity of the cut-away portion when the pack is closed.
Patent NZ-527238-A (NZ)
Title: Citrus fruit segmenter
Inventor: HOLCOMB DAVID A
IPC: A47J17/04
Filed: 2003-07-29
Abstract: A single-handedly operated citrus fruit segmenter having first and second arms such that squeezing the arms into a closed position causes a curved movable scoop to extend into a citrus fruit proximate to a triangular blade and form a segment-shaped compartment. The actuation of the curved movable scoop occurs by a user squeezing the first arm toward the second arm. A pin on the first arm is operatively connected to an elongated slot of a cam mechanism such that the rotation of the first arm about its pivot location causes the cam mechanism to rotate about its own pivot location. Therefore, the cam mechanism, being also connected to the curved movable scoop, forces the curved movable scoop into the citrus fruit.
Patent NZ-534369-A (NZ)
Title: Distalliative process of extracting and purifying phytosterols and phytostanols from tall oil pitch
Inventor: SCHULTZ MICHAEL E
IPC: C11B3/00
Filed: 2003-01-27
Abstract: A process for isolating and purifying phytosterols and phytostanols from tall oil pitch is disclosed which comprises the following steps: (a) feeding the pitch into a first distillation column; (b) distilling the pitch to remove excess rosin acids and fatty acids to form a distilled pitch; (c) saponifying the distilled pitch with an aqueous solution of one or more alkali metal bases to form a saponified pitch; (d) neutralizing the saponified pitch with an amount of acid sufficient to achieve an ending pH of between 5.8 and 6.3 thereby forming a neutralized pitch; (e) allowing the neutralized pitch to phase separate for a period of at least 12 hours or until the water content of the pitch, on phase separation, is less than 15%, thereby forming a settled pitch and a water phase; (f) removing substantially all of the remaining water from the settled pitch to form a modified pitch; (g) distilling the modified pitch in a second distillation column to remove lights ends from the modified pitch and to produce a bottom fraction comprising free phytosterols and/or phytostanols; (h) distilling only the bottom fraction in a third distillation column to produce a light phase distillate comprising free phytosterols and/or phytostanols; (i) dissolving only the light phase distillate in a solvent comprising at least one alcohol to produce a solution of phytosterols and/or phytostanols; (j) cooling the solution to form a slurry with phytosterols and/or phytostanols crystallized therein; and (k) washing, filtering and drying the slurry to isolate the crystallized phytosterols and/or phytostanols from the filtrate.
Patent NZ-537014-A (NZ)
Title: Combine vaccine against mycoplasma hyopneumoniae and porcine viruses
Inventor: CHU HSIEN-JUE
IPC: A61K39/116
Filed: 2003-05-14
Abstract: Disclosed is a vaccine composition for immunizing an animal against infection by Mycoplasma hyopneumoniae and a viral pathogen which comprises an immunizing amount of Mycoplasma hyopneumoniae bacterin; an immunizing amount of at least one viral antigen selected from the group consisting of swine influenza virus (SIV), porcine reproductive and respiratory syndrome virus (PRRSV), and porcine circovirus (PCV); an adjuvant mixture comprising an acrylic acid polymer and a mixture of a metabolizable oil and a polyoxyethylene-polyoxypropylene block copolymer; and a pharmaceutically acceptable carrier which vaccine composition after a single administration elicits protective immunity from Mycoplasma hyopneumoniae.
Patent NZ-539657-A (NZ)
Title: Indoles useful in the treatment of androgen-receptor related diseases
Inventor: STOCK HERMAN THIJS
IPC: C07D417/06
Filed: 2003-11-03
Abstract: Disclosed is a compound of formula (I), wherein: X is S, SO or SO2, R1 is a 5- or 6-membered monocyclic, hetero- or homocyclic, saturated or unsaturated ring structure optionally substituted with one or more substituents selected from the group consisting of halogen, CN, (1C-4C)fluoroalkyl, nitro, (1C-4C)alkyl, (1C-4C)alkyloxy or (1C-4C)fluoroalkyloxy; R2 is 2-nitrophenyl, 2-cyanophenyl, 2-hydroxymethyl-phenyl, pyridin-2-yl, pyridin2-yl-N-oxide, 2-benzamide, 2-benzoic acid methyl ester or 2-methoxyphenyl; and the remaining substituents are as defined in the specification. The compounds are useful in the treatment of androgen-receptor related conditions.
Patent NZ-540618-A (NZ)
Title: Carton for diagonally cut sandwiches
Inventor: MONEY JULIAN DAVID KYRLE
IPC: B65D5/36
Filed: 2003-12-10
Abstract: The disclosure relates to a carton for a diagonally cut sandwich or like foodstuff formed from a blank of card and having triangular end walls connected by rectangular side walls to form a triangular prism-shaped container. One side wall of the container is hinged to another wall of the container to provide an opening for insertion/removal of foodstuff and to form a lid for closing the opening. The edges of the opening have out-turned flanges and the periphery of the lid overlies the out-turned flanges encircling the opening when the lid is in the closed position whereby the lid can be bonded to the flanges to seal the contents of the carton.
Patent NZ-540741-A (NZ)
Title: An apparatus and method for determining a level of confidence in a risk assessment and/or determining a level of acceptability of an event occuring
Inventor: TSALAKOPOULOS CHRIS
IPC: G06Q40/08
Filed: 2003-11-20
Abstract: An apparatus (1) for assisting a user in determining a level of confidence in a risk assessment, the apparatus comprising: input means (3) for receiving at least one of a set of factors each of which can affect the level of confidence in the risk assessment; storage means (5) for storing the set of factors and a set of weighting indicators, wherein each factor within the set of factors is associated with a weighting indicator from the set of weighting indicators; processing means (7) for processing the at least one of the set of factors entered into the input means (3) and processing the set of factors stored in the storage means (3) in order to identify a factor in the set of factors which corresponds to the at least one factor entered into the input means (3); and output means (9) for outputting the set of weighting indicators and the weighting indicator associated with the factor identified by the processing means (7).
Patent NZ-545284-A (NZ)
Title: Pyrazole compounds useful as protein kinase inhibitors
Inventor: DAVIES ROBERT
IPC: A61P3/10
Filed: 2001-09-14
Abstract: Disclosed are 4-chloropyrimidine compounds of formula (B) are disclosed, wherein the variables are as defined in the specification. Also described are certain pyrazole compounds that are useful as protein kinase inhibitors, especially as inhibitors of aurora-2 and GSK-3, for treating diseases such as cancer, diabetes and Alzheimer's disease.
Patent NZ-547495-A (NZ)
Title: Multiplexed nucleic acid analysis by fragmentation of double-stranded DNA
Inventor: YANG JIACHENG
IPC: C12Q1/68
Filed: 2004-10-26
Abstract: Provided is a method of detecting particular nucleotide sequences in a double-stranded oligonucleotide sample, comprising: amplifying segments of the sample to generate double stranded amplicons; cleaving the double-stranded amplicons at locations which are not aligned between the amplicon strands, to thereby generate sense and anti-sense fragments which are not fully complementary; placing the fragments with a set of single-stranded oligonucleotides under annealing conditions, wherein single-stranded oligonucleotides in the set are complementary to the fragments or to subsequences of the fragments; and detecting hybridization between single-stranded oligonucleotides and the fragments. Further provided are similar methods wherein the frequency of labelling is adjusted depending on the predicted length of the sense and /or antisense fragments.
Patent NZ-549073-A (NZ)
Title: Thiol ester compositions and processes for making and using same
Inventor: REFVIK MITCHELL D
IPC: C05G3/90
Filed: 2005-02-17
Abstract: Disclosed is a controlled release fertilizer material which comprises a particulate plant nutrient surrounded by a coating which is the reaction product of a mixture comprising: (i) a first component selected from an isocyanate and/or an epoxy resin, and (ii) a first active hydrogen-containing compound selected from the group consisting of a) a thiol ester composition (A), b) a hydroxy thiol ester composition (B), c) a composition (C), and d) any combination of a), b), and c); where A) is a thiol ester composition which comprises thiol ester molecules derived from an unsaturated natural source oil or an unsaturated triglyceride, the thiol ester molecules having an average of at least 1.5 ester groups per thiol ester molecule, having an average of at least 1.5 thiol groups per thiol ester molecule, and having a molar ratio of cyclic sulphides to thiol groups of less than 1.5; B) is a hydroxy thiol ester composition which comprises hydroxy thiol ester molecules derived from an epoxidised unsaturated natural source oil or an epoxidised unsaturated triglyceride, the hydroxy thiol ester molecules having an average of at least 1.5 ester groups per hydroxy thiol ester molecule, having an average of at least 1.5 thiol groups per hydroxy thiol ester molecule, having an average of at least 1.5 hydroxy groups per hydroxy thiol ester molecule and having an average of at least 5 weight percent thiol sulphur per hydroxy thiol ester molecule; C) is a composition which comprises the thiol ester oligomers having at least two thiol ester monomers that are a) the thiol ester molecules as defined above (in part A), or b) the hydroxy thiol ester molecules as defined above (in part B) which are connected by a polysulfide linkage having a structure -SQ- , wherein Q is greater than 1.
Patent NZ-554893-A (NZ)
Title: Copper complexes and their use as wood preservatives
Inventor: ANDERSON ALBERT GORDON
IPC: B27K3/34
Filed: 2003-10-31
Abstract: Disclosed is a wood preservative composition comprising an aqueous solution of: a copper complex of a chelating compound comprising at least two functional groups selected from the group of amidoxime, hyroxamic acid, thiohydroxamic acid, N-hydroxyurea, N-hydroxycarbamate, and N-nitroso-alkyl-hydroxylamine; and ammonia, ethanolamine or pyridine in an amount sufficient to solubilize the copper complex. Also disclosed are processes of preparing copper complexes, processes of preparing preservative compositions and methods of treating articles with the wood preservative compositions.
Patent NZ-556397-A (NZ)
Title: Crystalline base of trans-1-((1R,3S)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine
Inventor: BANG-ANDERSEN BENNY
IPC: C07D295/073
Filed: 2006-02-14
Abstract: Disclosed is a crystalline base of the compound of formula (I), trans-1-((1R,3S)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine, pharmaceutical compositions comprising the compound and its use in the treatment of diseases such as schizophrenia, anxiety disorders, affective disorders, sleep disturbance, migraine and abuse disorders.
Patent NZ-563923-A (NZ)
Title: Post driving apparatus including a base plate which allows rotational movement, a stop mechanism including a worm gear and a hydraulic slew gear driving mechanism
Inventor: WHITE TONY GRAEME
Filed: 2007-11-29
Abstract: A post driving apparatus 1 includes a base plate 2, a stop mechanism associated with the base plate 2, a drive mechanism associated with said stop mechanism and a guide 4 attached to the base plate 2 for mounting a weight. The base plate 2 is adapted to allow at least 180° angle of movement in a substantially horizontal plane of the guide 4. The stop mechanism prevents unwanted movement the base plate when the post driving apparatus 1 is in use. The stop mechanism comprises a worm gear mechanism disposed in engagement with the drive mechanism. The drive mechanism comprises a hydraulic slew gear mechanism. Addition to 520276
Patent NZ-564379-A (NZ)
Title: Quinoline derivatives as antibacterial agents
Inventor: ANDRIES KOENRAAD JOZEF LODEWIJK MARCEL
IPC: A61K31/47
Filed: 2006-06-26
Abstract: Disclosed is the use of quinoline derivatives of formula (Ia) or (Ib), wherein the substituents are as defined in the specification, to treat bacterial infections other than Mycobacterial infections. Also disclosed are specific compounds of the formulas (Ia) and (Ib).
Patent NZ-565270-A (NZ)
Title: Method for predicting the response to a treatment with a HER dimerization inhibitor by assessing the level of expression of a marker protein encoded by the transforming growth factor (TGF) alpha marker gene
Inventor: MOECKS JOACHIM
IPC: C12Q1/68
Filed: 2006-05-24
Abstract: Disclosed is a method of predicting the response to a treatment with a HER dimerization inhibitor in a patient comprising the steps of: a) assessing in a biological sample from the patient, wherein the biological sample is blood serum, the level of expression of: - a marker protein encoded by the transforming growth factor alpha marker gene; or - a combination of marker proteins encoded by marker genes wherein the combination of marker proteins encoded by marker genes consists of the marker proteins encoded by: - the transforming growth factor alpha and the HER2 marker gene; - the transforming growth factor alpha and the epidermal growth factor marker gene; - the amphiregulin and the transforming growth factor alpha marker gene; - the transforming growth factor alpha, the epidermal growth factor and the HER2 marker gene; - the amphiregulin, the epidermal growth factor and the transforming growth factor alpha marker gene; - the amphiregulin, the transforming growth factor alpha and the HER2 marker gene; or - the amphiregulin, the epidermal growth factor, the transforming growth factor alpha and the HER2 marker gene, b) predicting the response to the treatment with the HER dimerization inhibitor in the patient by evaluating the results of step a), wherein the step a) of assessing the marker protein encoded by the marker gene or the combination of marker proteins encoded by the marker genes comprises a1) assessing the level of expression of the marker protein encoded by the marker gene or the combination of marker proteins encoded by the marker genes, a2) determining whether the level of expression assessed in step al) is above or below a threshold value, wherein a level of expression of either above or below the threshold value is predictive of either a positive or a negative response to treatment with the HER dimerization inhibitor.